Celeste Cagnazzo

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

Massimo Aglietta, Carlo Barone, M. B. Sawyer et al. · Annals of Oncology · 2014 · 221 citations · Full text

Medicine, Oncology, Pharmacology +12

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type <scp><i>KRAS</i></scp> advanced biliary tract cancer: A randomized phase 2 trial (<scp>V</scp>ecti‐<scp>BIL</scp> study)

Francesco Leone, Donatella Marino, Stefano Cereda et al. · Cancer · 2015 · 140 citations · Full text

Medicine, Oncology, Pharmacology +13

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O⁶-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial

Federica Morano, Alessandra Raimondi, Filippo Pagani et al. · Journal of Clinical Oncology · 2022 · 129 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2

Simone Cavalera, Barbara Colitti, Sergio Rosati et al. · Talanta · 2020 · 84 citations · Full text

Life Sciences, Biotechnology, Immunology +12

Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer

Filippo Montemurro, Gloria Mittica, Celeste Cagnazzo et al. · JAMA Oncology · 2015 · 77 citations · Full text

Medicine, Oncology, Breast Oncology +14